Who has invested in Candel Therapeutics?

No investors are named on the public record for Candel Therapeutics yet.

Candel Therapeutics Funding: $147M Raised, IPO (2021)

Candel Therapeutics funding overview

Candel Therapeutics is based in United States. Candel Therapeutics has raised $147M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is an IPO announced in September 2021. The round record for Candel Therapeutics runs through 2021; nothing later has been disclosed.

Candel Therapeutics at a glance

Total raised: $147M
Latest round: IPO
Latest round date: September 2021
Headquarters: United States

Frequently asked about Candel Therapeutics funding

How much has Candel Therapeutics raised?: Candel Therapeutics has raised $147M in total disclosed funding across the rounds on record.
Who has invested in Candel Therapeutics?: No investors are named on the public record for Candel Therapeutics yet.
What was the latest Candel Therapeutics funding round?: The most recent disclosed round is an IPO, announced in September 2021.
Where is Candel Therapeutics based?: Candel Therapeutics is based in United States.
When did Candel Therapeutics last raise?: The last disclosed Candel Therapeutics round closed in September 2021 at IPO.

Candel Therapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in United States below to benchmark round size and investor mix.

Candel Therapeutics Funding: $147M Raised, IPO (2021)

Candel Therapeutics funding overview

Candel Therapeutics at a glance

Frequently asked about Candel Therapeutics funding

Companies related to Candel Therapeutics (18)

Browse related funding lists (3)